# Healthier Choices Management Corp.: financial statements, quarterly

HCMC · OTC · CIK 844856 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hcmc.md) · [Financials](/companies/hcmc/financials.md) · [Filings](/companies/hcmc/filings.md) · [Insiders](/companies/hcmc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hcmc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.7](/filings/0001493152-23-040590.md) | [0.0 d](/filings/0001641172-25-004607.md) | [0.0](/filings/0001641172-25-009926.md) | [0.0](/filings/0001641172-25-023521.md) | [0.0](/filings/0001493152-25-021113.md) | [0.0 d](/filings/0001493152-26-013232.md) | [0.0](/filings/0001493152-26-022965.md) | [0.0](/filings/0001493152-26-039201.md) | [0.0](/filings/0001493152-25-021113.md) | [0.0 d](/filings/0001493152-26-013232.md) | not reported | not reported |
| Cost of revenue | $m | not reported | [0.0 d](/filings/0001641172-25-004607.md) | [0.0](/filings/0001641172-25-009926.md) | [0.0](/filings/0001641172-25-023521.md) | [0.0](/filings/0001493152-25-021113.md) | [0.1 d](/filings/0001493152-26-013232.md) | [0.0](/filings/0001493152-26-022965.md) | [0.0](/filings/0001493152-26-039201.md) | [0.0 d](/filings/0001493152-25-021113.md) | [0.0 d](/filings/0001493152-26-013232.md) | not reported | not reported |
| Gross profit | $m | [4.6](/filings/0001493152-23-040590.md) | [0.0 d](/filings/0001641172-25-004607.md) | [(0.0)](/filings/0001641172-25-009926.md) | [0.0](/filings/0001641172-25-023521.md) | [0.0](/filings/0001493152-25-021113.md) | [(0.1) d](/filings/0001493152-26-013232.md) | [0.0](/filings/0001493152-26-022965.md) | [(0.0)](/filings/0001493152-26-039201.md) | [0.0](/filings/0001493152-25-021113.md) | [(0.0) d](/filings/0001493152-26-013232.md) | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(2.1)](/filings/0001493152-24-045775.md) | [(2.0) d](/filings/0001641172-25-004607.md) | [(2.2)](/filings/0001641172-25-009926.md) | [(2.0)](/filings/0001641172-25-023521.md) | [(2.1)](/filings/0001493152-25-021113.md) | [(2.2) d](/filings/0001493152-26-013232.md) | [(2.2)](/filings/0001493152-26-022965.md) | [(2.0)](/filings/0001493152-26-039201.md) | [(2.1)](/filings/0001493152-25-021113.md) | [(0.8) d](/filings/0001493152-26-013232.md) | [(0.8)](/filings/0001493152-26-022965.md) | [0.1](/filings/0001493152-26-039201.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(3.0)](/filings/0001493152-24-045775.md) | [(10.9) d](/filings/0001641172-25-004607.md) | [(2.9)](/filings/0001641172-25-009926.md) | [(2.5)](/filings/0001641172-25-023521.md) | [(4.3)](/filings/0001493152-25-021113.md) | [(2.2) d](/filings/0001493152-26-013232.md) | [(2.2)](/filings/0001493152-26-022965.md) | [(2.0)](/filings/0001493152-26-039201.md) | [(2.1)](/filings/0001493152-25-021113.md) | [(0.8) d](/filings/0001493152-26-013232.md) | [(0.8)](/filings/0001493152-26-022965.md) | [0.1](/filings/0001493152-26-039201.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001493152-23-040590.md) | not reported | [0.00](/filings/0001493152-24-018493.md) | [0.00](/filings/0001493152-24-030401.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.00](/filings/0001493152-23-040590.md) | not reported | [0.00](/filings/0001493152-24-018493.md) | [0.00](/filings/0001493152-24-030401.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.2](/filings/0001493152-24-045775.md) | [3.7](/filings/0001641172-25-004607.md) | [1.2](/filings/0001641172-25-009926.md) | [3.4](/filings/0001493152-24-030401.md) | [2.5](/filings/0001493152-24-045775.md) | [1.2](/filings/0001493152-26-013232.md) | [1.2](/filings/0001641172-25-009926.md) | [1.1](/filings/0001641172-25-023521.md) | [1.1](/filings/0001493152-25-021113.md) | [1.1](/filings/0001493152-26-039201.md) | [1.1](/filings/0001493152-26-022965.md) | [1.2](/filings/0001493152-26-039201.md) |
| Current assets | $m | [13.6](/filings/0001493152-23-040590.md) | [11.7](/filings/0001641172-25-004607.md) | [11.4](/filings/0001493152-24-018493.md) | [11.0](/filings/0001493152-24-030401.md) | [3.4](/filings/0001493152-24-045775.md) | [1.9](/filings/0001493152-26-013232.md) | [1.4](/filings/0001641172-25-009926.md) | [1.3](/filings/0001641172-25-023521.md) | [1.3](/filings/0001493152-25-021113.md) | [1.3](/filings/0001493152-26-039201.md) | [1.3](/filings/0001493152-26-022965.md) | [1.4](/filings/0001493152-26-039201.md) |
| Total assets | $m | [37.1](/filings/0001493152-23-040590.md) | [31.0](/filings/0001641172-25-004607.md) | [29.1](/filings/0001493152-24-018493.md) | [27.6](/filings/0001493152-24-030401.md) | [3.8](/filings/0001493152-24-045775.md) | [2.2](/filings/0001493152-26-013232.md) | [1.7](/filings/0001641172-25-009926.md) | [1.5](/filings/0001641172-25-023521.md) | [1.5](/filings/0001493152-25-021113.md) | [1.5](/filings/0001493152-26-039201.md) | [1.4](/filings/0001493152-26-022965.md) | [1.5](/filings/0001493152-26-039201.md) |
| Current liabilities | $m | [9.3](/filings/0001493152-23-040590.md) | [12.2](/filings/0001641172-25-004607.md) | [12.9](/filings/0001493152-24-018493.md) | [13.6](/filings/0001493152-24-030401.md) | [3.2](/filings/0001493152-24-045775.md) | [2.7](/filings/0001493152-26-013232.md) | [3.2](/filings/0001641172-25-009926.md) | [3.9](/filings/0001641172-25-023521.md) | [4.9](/filings/0001493152-25-021113.md) | [1.6](/filings/0001493152-26-039201.md) | [2.1](/filings/0001493152-26-022965.md) | [2.1](/filings/0001493152-26-039201.md) |
| Total liabilities | $m | [18.7](/filings/0001493152-23-040590.md) | [23.1](/filings/0001641172-25-004607.md) | [23.0](/filings/0001493152-24-018493.md) | [22.8](/filings/0001493152-24-030401.md) | [3.2](/filings/0001493152-24-045775.md) | [2.7](/filings/0001493152-26-013232.md) | [3.2](/filings/0001641172-25-009926.md) | [3.9](/filings/0001641172-25-023521.md) | [4.9](/filings/0001493152-25-021113.md) | [1.6](/filings/0001493152-26-013232.md) | not reported | not reported |
| Long-term debt | $m | [2.0](/filings/0001493152-23-040590.md) | [2.4](/filings/0001493152-24-030401.md) | [2.2](/filings/0001493152-24-018493.md) | [2.0](/filings/0001493152-24-030401.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.6](/filings/0001493152-23-040590.md) | [1.2](/filings/0001493152-24-030401.md) | [2.9](/filings/0001493152-24-018493.md) | [2.9](/filings/0001493152-24-030401.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [16.4](/filings/0001493152-24-045775.md) | [6.8](/filings/0001493152-26-013232.md) | [5.0](/filings/0001641172-25-023521.md) | [3.7](/filings/0001493152-25-021113.md) | [(0.5)](/filings/0001493152-25-021113.md) | [(1.6)](/filings/0001493152-26-039201.md) | [(2.6)](/filings/0001493152-26-039201.md) | [(3.5)](/filings/0001493152-26-039201.md) | [(4.4)](/filings/0001493152-25-021113.md) | [(1.2)](/filings/0001493152-26-039201.md) | [(1.8)](/filings/0001493152-26-039201.md) | [(1.7)](/filings/0001493152-26-039201.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,281) d](/filings/0001493152-23-040590.md) | [200 d](/filings/0001641172-25-004607.md) | [(2,374)](/filings/0001641172-25-009926.md) | [(97.3) d](/filings/0001641172-25-023521.md) | [438 d](/filings/0001493152-25-021113.md) | [(1,622) d](/filings/0001493152-26-013232.md) | [(985)](/filings/0001493152-26-022965.md) | [(1,008) d](/filings/0001493152-26-039201.md) | [(1,066) d](/filings/0001493152-25-021113.md) | [(823) d](/filings/0001493152-26-013232.md) | [(609)](/filings/0001493152-26-022965.md) | [(12.0) d](/filings/0001493152-26-039201.md) |
| Capital expenditure | $k | [28.1 d](/filings/0001493152-24-045775.md) | [8.2 d](/filings/0001641172-25-004607.md) | [47.2](/filings/0001641172-25-009926.md) | [0.0 d](/filings/0001641172-25-023521.md) | [(0.0) d](/filings/0001493152-25-021113.md) | [0.0 d](/filings/0001493152-26-013232.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [340](/filings/0001493152-23-040590.md) | [342](/filings/0001493152-24-018493.md) | [354](/filings/0001493152-24-030401.md) | [358](/filings/0001493152-24-045775.md) | [430](/filings/0001641172-25-009926.md) | [479](/filings/0001641172-25-023521.md) | [480](/filings/0001493152-25-021113.md) | [481](/filings/0001493152-26-022965.md) | [481](/filings/0001493152-26-039201.md) | [481](/filings/0001493152-25-021113.md) | [526](/filings/0001493152-26-022965.md) | [527](/filings/0001493152-26-039201.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 527,156,418,606 at 2026-08-19, from the cover of the [10-Q filed 2026-08-19](/filings/0001493152-26-039201.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.